Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid‐Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease

BACKGROUND: Patients with diabetes mellitus and cardiovascular disease may not achieve adequate low‐density lipoprotein cholesterol (LDL‐C) lowering on statin monotherapy, attributed partly to atherogenic dyslipidemia. More intensive LDL‐C–lowering therapy can be considered for these patients. A pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Ngoc‐Anh, Tomassini, Joanne E., Tershakovec, Andrew M., Neff, David R., Wilson, Peter W. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845107/
https://www.ncbi.nlm.nih.gov/pubmed/26486166
http://dx.doi.org/10.1161/JAHA.114.001675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845107/
https://www.ncbi.nlm.nih.gov/pubmed/26486166
http://dx.doi.org/10.1161/JAHA.114.001675

Ejemplares similares